JPRN-UMIN000029962已完成未知
Clinical trial of mesenchymal stem cell mobilization factor KOI2 in epidermolysis bullosa patients - Clinical trial of KOI2 in epidermolysis bullosa patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Epidermolysis bullosa other than malnutrition type (2) Urine pregnancy test is positive (female only) at screening visit (3) Breast feeding female patient (4) HIV, HBs, HCV positive at screening (5) A subject who participated in other clinical trials within 90 days and received a clinical trial drug (including a placebo) (6) A subject who is participating in any other clinical trials. (7) A subject whose liver dysfunction data match the predefined exclusion standard (8) A subject who has acute worsening of epidermolysis bullosa (such as tracheal/esophageal stenosis, acute nephritis) (9) Ineligible by other reasons judged by the investigators
研究者
相似试验
进行中（未招募）
1 期
Clinical research using the mesenchymal stem cells from autologous fat tissue of Alzheimer dementiaJPRN-jRCTb050190035OOYAMA TAKAYUKI3
已完成
不适用
Clinical trial of mesenchymal stem cell transplantation for severe heart failureSevere chronic heart failureJPRN-UMIN000000656ational Cardiovascular Center20
撤回
不适用
Application of mesenchymal stem cells in patients with end-stage renal diseaseNL-OMON34665Erasmus MC, Universitair Medisch Centrum Rotterdam16
招募中
1 期
Cell therapy with use of mesenchymal stem cells in infertile women with Thin EndometriumIRCT20230222057500N1Tehran University of Medical Sciences10
进行中（未招募）
不适用
Mesenchymal stem cell based therapy for the treatment of osteogenesis imperfectaOsteogenesis imperfecta (OI) is a rare genetic disorder with increased bone fragility of varying severity. In the majority of patients the disease is caused by mutations in collagen type I. Severe OI is characterized by osteopenia, frequent fractures, progressive deformity, short stature, loss of mobility, chronic pain and can lead to premature death. At present a cure does not exist.EUCTR2012-002553-38-ESItziar Astigarraga Aguirre